iTeos Therapeutics rises after reporting narrower-than-expected quarterly loss

iTeos Therapeutics

05/03/2025 19:07

** Shares of cancer drug developer iTeos Therapeutics ITOS.O rise 4.5% to $7.15 in the afternoon trade

** Company reports Q4 net loss of $1.01 per share, compared to analysts' estimates of a loss of $1.06 per share, according to data compiled by LSEG

** ITOS expects its cash balance of $655 million to provide a runway through 2027

** ITOS down 38.2% in the past 12 months

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))